{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T09:54:38Z","timestamp":1766138078851},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To optimize antibiotic treatment and decrease antibiotic resistance, national treatment guidelines are available for urinary tract infections (UTIs) in general practice. The usefulness of these guidelines in risk areas for antimicrobial resistance such as cross border regions or areas with dense agriculture, is unknown.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Midstream urine samples from women with symptoms of acute UTI visiting general practitioners (GPs) in the Westland area, a dense agriculture area, were microbiologically analysed, and patient characteristics, symptoms, previous and present antibiotic treatment were collected. The National Nivel data were used as reference for antibiotic resistance.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 310 women with symptoms of uncomplicated UTI, 247 (80%) had a culture proven <jats:italic>E. coli<\/jats:italic> UTI. Empirical antibiotic therapy was prescribed to 148 patients (48%) in total; in 7% of women with a negative and 52% with a positive urine culture. Having more than one symptom was associated with the prescription of antibiotics; travel history or previous antibiotic use for UTI were not. The isolated uropathogens were susceptible to the empiric antibiotic therapy in 98% of patients. Resistance to co-amoxiclav was higher (22%) than reported in the national data of 2004 (12%), 2009 (13%) and 2014 (9%), as was the prevalence of extended spectrum \u03b2-lactamase (ESBL): 3.4% in our study versus 0.1%, 1% and 2.2% in the national data respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The presence of environmental and socio-demographic risk factors for antibiotic resistance did not influence the empiric choice nor susceptibility for antibiotics advised by the national guidelines in women with uncomplicated UTI.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12875-022-01840-6","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T10:06:37Z","timestamp":1662545197000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Adherence to and usefulness of the national treatment guideline for urinary tract infections (UTI) in a risk area"],"prefix":"10.1186","volume":"23","author":[{"given":"A. A.","family":"van Driel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. E.","family":"Stobberingh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Verbon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,7]]},"reference":[{"key":"1840_CR1","unstructured":"ECDC. Surveillance of Antimicrobial Resistance in Europe. 2017. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/EARS-Net-report-2017-update-jan-2019.pdf. (Accessed 12 Dec 2019)."},{"key":"1840_CR2","unstructured":"NIVEL. National institute of health research. https:\/\/www.nivel.nl\/nl\/nieuws\/percentage-patienten-dat-antibioticum-krijgt-voorgeschreven-daalt-iets?utm_source=NIVEL%20attendering&utm_campaign=aa490a2618-2018_10_25_antibioticum&utm_medium=email&utm_term=0_caebd11ec3-aa490a2618-98601505. (Accessed 2 Jun 2020). Dutch"},{"key":"1840_CR3","unstructured":"Standaard urineweginfecties NHG richtlijn. Dutch.\u00a0https:\/\/richtlijnen.nhg.org\/standaarden\/urineweginfecties. Accessed 10 June\u00a02020."},{"issue":"2","key":"1840_CR4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/jac\/dkx397","volume":"73","author":"A Dorado-Garc\u00eda","year":"2018","unstructured":"Dorado-Garc\u00eda A, Smid JH, van Pelt W, J, et al. Molecular relatedness of ESBL\/AmpC-producing Escherichia coli from humans, animals, food and the environment: a pooled analysis. Antimicrob Chemother. 2018;73(2):339\u201347.","journal-title":"Antimicrob Chemother."},{"issue":"6","key":"1840_CR5","doi-asserted-by":"publisher","first-page":"E256","DOI":"10.1111\/1469-0691.12150","volume":"19","author":"PM Huijbers","year":"2013","unstructured":"Huijbers PM, de Kraker M, Graat EA, et al. Prevalence of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae in humans living in municipalities with high and low broiler density. Clin Microbiol Infect. 2013;19(6):E256\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"1840_CR6","unstructured":"CLO. Compendium of living environment https:\/\/www.clo.nl\/indicatoren\/nl0565-antibioticagebruik-in-de-veehouderij. (Accessed 2 Jun 2020). Dutch"},{"key":"1840_CR7","doi-asserted-by":"publisher","unstructured":"Kurenbach B, Marjoshi D, Am\u00e1bile-Cuevas CF, et al. Sublethal exposure to commercial formulations of the herbicides dicamba, 2,4-dichlorophenoxyacetic acid, and glyphosate cause changes in antibiotic susceptibility in Escherichia coli and Salmonella enterica serovar Typhimurium. MBio.\u00a02015;6(2):e00009\u201315. https:\/\/doi.org\/10.1128\/mBio.00009-15.","DOI":"10.1128\/mBio.00009-15"},{"key":"1840_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.scitotenv.2017.10.312","volume":"616\u2013617","author":"J Jutkina","year":"2018","unstructured":"Jutkina J, Marathe NP, Flach CF, et al. Antibiotics and common antibacterial biocides stimulate horizontal transfer of resistance at low concentrations. Sci Total Environ. 2018;616\u2013617:172\u20138.","journal-title":"Sci Total Environ"},{"key":"1840_CR9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.scitotenv.2017.10.309","volume":"616\u2013617","author":"AHC Van Bruggen","year":"2018","unstructured":"Van Bruggen AHC, He MM, Shin K, et al. Environmental and health effects of the herbicide glyphosate. Sci Total Environ. 2018;616\u2013617:255\u201368 (Review.).","journal-title":"Sci Total Environ."},{"issue":"3-4","key":"1840_CR10","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.vetmic.2014.03.007","volume":"171","author":"H Blaak","year":"2014","unstructured":"Blaak H, de Kruijf P, Hamidjaja RA, et al. Prevalence and characteristics of ESBL-producing E. coli in Dutch recreational waters influenced by wastewater treatment plants. Vet Microbiol. 2014;171(3\u20134):448\u201359.","journal-title":"Vet Microbiol."},{"issue":"5","key":"1840_CR11","doi-asserted-by":"publisher","first-page":"14372","DOI":"10.1038\/srep14372","volume":"24","author":"E Franz","year":"2015","unstructured":"Franz E, Veenman C, van Hoek AH, et al. Pathogenic Escherichia coli producing Extended-Spectrum \u03b2-Lactamases isolated from surface water and wastewater. Sci Rep. 2015;24(5):14372.","journal-title":"Sci Rep"},{"key":"1840_CR12","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1007\/s10096-014-2142-7","volume":"33","author":"EA Reuland","year":"2014","unstructured":"Reuland EA, Al Naiemi N, Raadsen SA, et al. Prevalence of ESBL-producing Enterobacteriaceae in raw vegetables. Eur J Clin Microbiol Infect Dis. 2014;33:1843\u20136.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"10","key":"1840_CR13","doi-asserted-by":"publisher","first-page":"e0186576","DOI":"10.1371\/journal.pone.0186576","volume":"12","author":"SB J\u00f8rgensen","year":"2017","unstructured":"J\u00f8rgensen SB, S\u00f8raas AV, Arnesen LS, et al. A comparison of extended spectrum \u03b2-lactamase producing Escherichia coli from clinical, recreational water and wastewater samples associated in time and location. PLoS ONE. 2017;12(10):e0186576.","journal-title":"PLoS ONE"},{"key":"1840_CR14","doi-asserted-by":"publisher","unstructured":"Hassing RJ, Alsma J, Arcilla MS, et al. International\u00a0travel\u00a0and\u00a0acquisition\u00a0of\u00a0multidrug-resistant\u00a0Enterobacteriaceae: a\u00a0systematic\u00a0review. Surveill. 2015;20(47). https:\/\/doi.org\/10.2807\/1560-7917.ES.2015.20.47.30074.","DOI":"10.2807\/1560-7917.ES.2015.20.47.30074"},{"issue":"1","key":"1840_CR15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1473-3099(16)30319-X","volume":"17","author":"MS Arcilla","year":"2017","unstructured":"Arcilla MS, van Hattem JM, Haverkate MR, et al. Import and spread of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study. Lancet Infect Dis. 2017;17(1):78\u201385.","journal-title":"Lancet Infect Dis"},{"key":"1840_CR16","unstructured":"EARS 2017. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/surveillance-antimicrobial-resistance-europe-2017 (Accessed 2 May 2019)."},{"issue":"11","key":"1840_CR17","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.4065\/mcp.2011.0358","volume":"86","author":"S Doron","year":"2011","unstructured":"Doron S, Davidson LE. Antimicrobial stewardship. Mayo Clin Proc. 2011;86(11):1113\u201323.","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"1840_CR18","doi-asserted-by":"publisher","first-page":"e027221","DOI":"10.1136\/bmjopen-2018-027221","volume":"9","author":"M Mulder","year":"2019","unstructured":"Mulder M, Baan E, Verbon A, et al. Trends of prescribing antimicrobial drugs for urinary tract infections in primary care in the Netherlands: a population-based cohort study. BMJ Open. 2019;9(5):e027221.","journal-title":"BMJ Open"},{"issue":"11","key":"1840_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1471-2296-11-51","volume":"28","author":"M Lugtenberg","year":"2010","unstructured":"Lugtenberg M, Burgers JS, Zegers-van Schaick JM, et al. Guidelines on uncomplicated urinary tract infections are difficult to follow: perceived barriers and suggested interventions. BMC Fam Pract. 2010;28(11):51.","journal-title":"BMC Fam Pract"},{"issue":"20","key":"1840_CR20","first-page":"e41","volume":"31","author":"KMJ Ganzeboom","year":"2018","unstructured":"Ganzeboom KMJ, Uijen AA, Teunissen DTAM, et al. Urine cultures and antibiotics for urinary tract infections in Dutch general practice. Prim Health Care Res Dev. 2018;31(20):e41.","journal-title":"Prim Health Care Res Dev"},{"key":"1840_CR21","unstructured":"CBS. https:\/\/opendata.cbs.nl\/statline\/#\/CBS\/nl\/dataset\/80781ned\/table?dl=39E8D (Accessed 24 Aug 2020). Dutch"},{"key":"1840_CR22","unstructured":"CBS. https:\/\/www.cbs.nl\/nl-nl\/nieuws\/2019\/14\/bijna-60-procent-arbeidsmigranten-binnen-zes-jaar-weg (Accessed 24 Aug 2020). Dutch"},{"issue":"15","key":"1840_CR23","first-page":"720","volume":"145","author":"TJ Wiersma","year":"2001","unstructured":"Wiersma TJ. Guidelines for diagnosing urinary tract infections: advantages and disadvantages of various methods. Ned Tijdschr Geneeskd. 2001;145(15):720\u20136 (Review. Dutch).","journal-title":"Ned Tijdschr Geneeskd."},{"key":"1840_CR24","unstructured":"EUCAST clinical breakpoints.\u00a0http:\/\/www.eucast.org\/clinical_breakpoints\/. Accessed 10 June 2020.\u00a0"},{"key":"1840_CR25","unstructured":"NVMM, NVMM-richtlijn voor screening en confirmatie van extended-spectrum beta-lactamases (ESBL's) in Enterobacteriaceae. https:\/\/www.nvmm.nl\/media\/1051\/2012_hrmo_mrsa_esbl.pdf (Last revision 2017) Dutch"},{"issue":"5","key":"1840_CR26","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/jac\/dkl082","volume":"57","author":"S Nys","year":"2006","unstructured":"Nys S, van Merode T, Bartelds AI, Stobberingh EE. Urinary tract infections in general practice patients: diagnostic tests versus bacteriological culture. J Antimicrob Chemother. 2006;57(5):955\u20138 (Epub 2006 Mar 22).","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"1840_CR27","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ijantimicag.2005.10.015","volume":"27","author":"S Nys","year":"2006","unstructured":"Nys S, van Merode T, Bartelds AI, Stobberingh EE. Antibiotic treatment and resistance of unselected uropathogens in the elderly. Int J Antimicrob Agents. 2006;27(3):236\u201341.","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"1840_CR28","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1093\/jac\/dkq286","volume":"65","author":"CD den Heijer","year":"2010","unstructured":"den Heijer CD, Donker GA, Maes J, Stobberingh EE. Antibiotic susceptibility of unselected uropathogenic Escherichia coli from female Dutch general practice patients: a comparison of two surveys with a 5 year interval. J Antimicrob Chemother. 2010;65(10):2128\u201333.","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"1840_CR29","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1007\/s10096-019-03655-3","volume":"38","author":"AA van Driel","year":"2019","unstructured":"van Driel AA, Notermans DW, Meima A, et al. Antibiotic resistance of Escherichia coli isolated from uncomplicated UTI in general practice patients over a 10-year period. Eur J Clin Microbiol Infect Dis. 2019;38(11):2151\u20138.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1840_CR30","unstructured":"Donker G Continuous Morbidity Registration at Dutch Sentinel Stations, 2008. Utrecht Netherlands Institute for Health Services Research (NIVEL), 2010."},{"key":"1840_CR31","unstructured":"CBS. https:\/\/opendata.cbs.nl\/statline\/#\/CBS\/nl\/dataset\/71466ned\/table?fromstatweb (Accessed 24 Aug 2020). Dutch"},{"key":"1840_CR32","unstructured":"Gezondheidsmonitor. https:\/\/gezondheidsmonitor.ggdhaaglanden.nl\/gemeenten\/westland\/themas\/bevolking\/midden-oost-en-zuid-europeanen\/ (aantal migranten westland) (Accessed 4 Jun 2020). Dutch"},{"key":"1840_CR33","unstructured":"Onderzoeksrapport OBO. Research pesticides and local residents. https:\/\/www.rivm.nl\/documenten\/onderzoeksrapport-obo (accessed 24 Aug 2020). Dutch"},{"key":"1840_CR34","unstructured":"Nethmap 2019: https:\/\/www.rivm.nl\/bibliotheek\/rapporten\/2019-0038.pdf (Accessed 24 Aug 2020). Dutch"},{"key":"1840_CR35","unstructured":"SWAB. https:\/\/www.swab.nl\/swab\/cms3.nsf\/uploads\/4F5A0D8E6F0DD139C1257E6E0051833A\/$FILE\/NethmapMaran2015%20_webversie.pdf (Accessed 24 Aug 2020). Dutch"},{"key":"1840_CR36","unstructured":"NHG standaarden. https:\/\/www.nhg.org\/standaarden\/volledig\/nhg-standaard-urineweginfecties (Accessed 24 Aug 2020). Dutch"},{"issue":"9","key":"1840_CR37","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s10096-016-2685-x","volume":"35","author":"SS Ahmed","year":"2016","unstructured":"Ahmed SS, Alp E, Ulu-Kilic A, et al. Spread of carbapenem-resistant international clones of Acinetobacter baumannii in Turkey and Azerbaijan: a collaborative study. Eur J Clin Microbiol Infect Dis. 2016;35(9):1463\u20138.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"1840_CR38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13756-018-0455-5","volume":"7","author":"SJ Ravensbergen","year":"2019","unstructured":"Ravensbergen SJ, Louka C, Ott A, et al. Proportion of asylum seekers carrying multi-drug resistant microorganisms is persistently increased after arrival in the Netherlands. Antimicrob Resist Infect Control. 2019;7(8):6.","journal-title":"Antimicrob Resist Infect Control"},{"key":"1840_CR39","unstructured":"WHO. https:\/\/www.who.int\/mediacentre\/news\/releases\/2014\/amr-report (Accessed 2 May 2020)."}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-022-01840-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-022-01840-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-022-01840-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T12:39:22Z","timestamp":1664973562000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-022-01840-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1840"],"URL":"https:\/\/doi.org\/10.1186\/s12875-022-01840-6","relation":{},"ISSN":["2731-4553"],"issn-type":[{"value":"2731-4553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,7]]},"assertion":[{"value":"28 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The need for ethics was waived for our study by the board of medical ethics committee Erasmus MC of Rotterdam\u00a0(MEC-2017\u20131167), because of the anonymous retrospective nature of the study and the use of residual material.The study was performed in accordance with the Guidelines for Good Clinical Practice (ICH-GCP), the Declaration of Helsinki in its latest version and international and local laws.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"224"}}